Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 211.00
Ask: 212.50
Change: -1.00 (-0.47%)
Spread: 1.50 (0.711%)
Open: 207.00
High: 212.50
Low: 207.00
Prev. Close: 212.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 Jul 2012 13:56

RNS Number : 9179G
Advanced Medical Solutions Grp PLC
04 July 2012
 



 

 

 

 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MED.SLTN.GP.

 

 

2. Reason for the notification  (please tick the appropriate box or boxes)

 

 

An acquisition or disposal of voting rights

X

 

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

 

An event changing the breakdown of voting rights

 

 

Other (please specify): ___________

 

 

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited

 

 

4. Full name of shareholder(s) (if different from 3.):

 

 

5. Date of the transaction and date on which the threshold is crossed or reached if different:

02/07/2012

 

 

6. Date on which issuer notified:

03/07/2012

 

 

7. Threshold(s) that is/are crossed or reached:

3%

 

8.Notified details: Nominee holdings

 

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

 

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

 

Direct

Direct

Indirect

Direct

Indirect

 

0453659

4,651,448

2.28%

 

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

CFD's

 

1,449,690

 

 

0.71%

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,101,138.00

2.99%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd (3,592,946.00 1.76%)

State Street Nominees (1,058,502.00 0.52%)

HSBC (778,690.00 0.38%)

Merrill Lynch (671,000.00 0.33%)

 

 

 

 

 

 

 

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 204,180,880

14. Contact name:

Stuart Caldwell

15. Contact telephone number:

0141 222 8128

Note: Annex should only be submitted to the FSA not the issuer

 

Annex: Notification of major interests in shares

A: Identity of the persons or legal entity subject to the notification obligation

Full name (including legal form of legal entities)

Stephanie Griffin

Contact address (registered office for legal entities)

50 Bothwell Street, Glasgow, G2 6HR

Phone number & email

0141 222 8286

Other useful information (at least legal representative for legal persons)

Stephanie Griffin

 

B: Identity of the notifier, if applicable

Full name

Stuart Caldwell

Contact address

50 Bothwell Street, Glasgow, G2 6HR

Phone number

0141 222 8128

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Senior Analyst

 

 C: Additional information

 

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSSURUNABRAR
Date   Source Headline
30th Jul 20197:00 amRNSFDA approval for two advanced woundcare ranges
28th Jun 20192:23 pmRNSTotal Voting Rights
21st Jun 20197:00 amRNSTrading Update
5th Jun 20195:29 pmRNSResult of AGM
5th Jun 20197:00 amRNSNotice of AGM
31st May 20193:10 pmRNSTotal Voting Rights
14th May 20197:00 amRNSIDE received for LiquiBand Fix8 in US
30th Apr 20194:56 pmRNSTotal Voting Rights
30th Apr 20199:40 amRNSNotice of Annual General Meeting and Annual Report
29th Apr 20195:27 pmRNSDirector/PDMR Shareholding
4th Apr 201910:16 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSUnaudited preliminary results
6th Mar 20199:13 amRNSBlock listing Interim Review
4th Mar 20192:24 pmRNSHolding(s) in Company
19th Feb 20197:00 amRNSNotice of Results
12th Feb 20194:23 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSAcquisition of Sealantis
31st Dec 20187:00 amRNSManagement Change
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSFix8 approved in Europe
18th Dec 20187:00 amRNSTrading Update
30th Nov 20181:40 pmRNSTotal Voting Rights
9th Nov 20183:06 pmRNSHoldings in Company
6th Nov 20184:33 pmRNSApplication for Admission
2nd Nov 201811:13 amRNSHolding(s) in Company
31st Oct 20185:20 pmRNSTotal Voting Rights
17th Sep 20184:30 pmRNSHolding(s) in Company
12th Sep 20187:00 amRNSInterim Results
31st Aug 20184:08 pmRNSApplication for Admission
10th Aug 20187:00 amRNSFDA approval for two woundcare portfolio dressings
7th Aug 20185:22 pmRNSHoldings in Company
27th Jul 20187:00 amRNSNotice of Interim Results
26th Jul 20183:23 pmRNSHoldings in Company
25th Jul 20182:26 pmRNSHoldings in Company
18th Jul 201812:28 pmRNSHolding(s) in Company
5th Jul 20187:00 amRNSTrading Update
29th Jun 20183:42 pmRNSTotal Voting Rights
28th Jun 20184:36 pmRNSDirector/PDMR Shareholding
11th Jun 20185:12 pmRNSDirector/PDMR Shareholding
6th Jun 201812:15 pmRNSResult of AGM
6th Jun 20187:00 amRNSNotice of AGM and Management Change
31st May 20183:49 pmRNSTotal Voting Rights
3rd May 20186:29 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20185:12 pmRNSDirector/PDMR and PCA Shareholding
3rd May 201812:27 pmRNSDirector Declaration
30th Apr 20185:02 pmRNSTotal Voting Rights
26th Apr 20187:00 amRNSNotice of Annual General Meeting and Annual Report
18th Apr 20189:45 amRNSDirector/PDMR and PCA Shareholding
5th Apr 20185:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.